Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0170
0.00 (0.00%)
At close: Mar 27, 2026
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of 29.19 million as of March 27, 2026. Its market cap has increased by 188.27% in one year.
Market Cap
29.19M
Enterprise Value
27.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 12.17M to 29.19M, an increase of 139.85%. That is a compound annual growth rate of 4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 29.19M | 23.44% |
| Dec 31, 2025 | 23.64M | 133.52% |
| Dec 30, 2024 | 10.12M | -39.06% |
| Dec 29, 2023 | 16.61M | 7.70% |
| Dec 30, 2022 | 15.42M | 185.23% |
| Dec 30, 2021 | 5.41M | -32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prescient Therapeutics | 56.78M |
| Imugene | 49.98M |
| Proteomics International Laboratories | 49.56M |
| Entropy Neurodynamics | 46.90M |
| EZZ Life Science Holdings | 40.24M |
| Avecho Biotechnology | 33.06M |
| NeuroScientific Biopharmaceuticals | 27.27M |
| Argenica Therapeutics | 20.55M |